Literature DB >> 15311112

Stimulation of calcitonin gene-related peptide synthesis and release: mechanisms for a novel antihypertensive drug, rutaecarpine.

Pan-Yue Deng1, Feng Ye, Wei-Jun Cai, Gui-Shan Tan, Chang-Ping Hu, Han-Wu Deng, Yuan-Jian Li.   

Abstract

BACKGROUND: Previous investigations have demonstrated that capsaicin-sensitive primary sensory nerves play an important role in modulation of the peripheral resistance of the circulation system. The vanilloid receptor subtype 1 (VR1) is expressed almost exclusively in the primary sensory nerves and cell bodies of these sensory neurons. Rutaecarpine (Rut) can relax vascular smooth muscle via stimulation of calcitonin gene-related peptide (CGRP) release by activation of VR1.
METHODS: In the present study, we examined the depressor effect of Rut and the possible mechanisms in the phenol-induced hypertensive rats, in which hypertension was induced by injecting 50 microl of 10% phenol in the lower pole of the left kidney.
RESULTS: Acute administration of Rut (30, 100 or 300 microg/kg, i.v.) caused a depressor effect concomitantly with an increase in the plasma concentration of CGRP in a dose-dependent manner, which was blocked by capsaicin (used to deplete the CGRP from sensory nerves) or capsazepine (a competitive VR1 antagonist), causing an approximately 85% and approximately 80% change in mean arterial pressure, respectively, and by either of them, causing an approximately 90% elevation of plasma CGRP. In the chronic study, Rut at a dose of 3 or 6 mg/kg per day significantly lowered tail-cuff systolic blood pressure to 159 +/- 8 and 136 +/- 10 mmHg, respectively, compared with hypertensive rats (179 +/- 8 mmHg), and caused a sustained hypotensive effect from day 6 on. Pretreatment with capsaicin blocked the depressor effect of Rut by approximately 65%. Treatment with Rut significantly increased the synthesis and release of CGRP, as shown by the increase in the levels of CGRP mRNA and peptide in the dorsal root ganglia, the density of CGRP immunoreactive nerve fibers in the mesenteric artery, the CGRP content in the spinal cord and the plasma concentration of CGRP, which was markedly attenuated by pretreatment with capsaicin.
CONCLUSION: These results suggest, for the first time, that the hypotensive effect of Rut is mediated by stimulation of CGRP synthesis and release via activation of VR1 in the phenol-induced hypertensive rat.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15311112     DOI: 10.1097/00004872-200409000-00028

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  12 in total

1.  The protective effects of rutaecarpine on acute pancreatitis.

Authors:  Lu Yan; Qing-Fu Li; Yan-Ting Rong; Yong-Heng Chen; Zhao-Hong Huang; Zhi-Zhi Wang; Jie Peng
Journal:  Oncol Lett       Date:  2017-12-20       Impact factor: 2.967

2.  Stimuli of sensory-motor nerves terminate arterial contractile effects of endothelin-1 by CGRP and dissociation of ET-1/ET(A)-receptor complexes.

Authors:  Merlijn J P M T Meens; Matthijs G Compeer; Tilman M Hackeng; Marc A van Zandvoort; Ben J A Janssen; Jo G R De Mey
Journal:  PLoS One       Date:  2010-06-01       Impact factor: 3.240

3.  Rutaecarpine inhibits angiotensin II-induced proliferation in rat vascular smooth muscle cells.

Authors:  Yan-ju Li; Feng Zhang; Qi-hai Gong; Qin Wu; Li-mei Yu; An-sheng Sun
Journal:  Chin J Integr Med       Date:  2013-06-17       Impact factor: 1.978

4.  Involvement of prolylcarboxypeptidase in the effect of rutaecarpine on the regression of mesenteric artery hypertrophy in renovascular hypertensive rats.

Authors:  Xu-Ping Qin; Si-Yu Zeng; Hai-Hong Tian; Shui-Xiu Deng; Jun-Fang Ren; Yuan-Bin Zheng; Dai Li; Yuan-Jian Li; Duan-Fang Liao; Shi-You Chen
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-10-31       Impact factor: 2.557

Review 5.  Calcitonin gene-related peptide: physiology and pathophysiology.

Authors:  F A Russell; R King; S-J Smillie; X Kodji; S D Brain
Journal:  Physiol Rev       Date:  2014-10       Impact factor: 37.312

Review 6.  Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension.

Authors:  I Márquez-Rodas; F Longo; R P Rothlin; G Balfagón
Journal:  J Physiol Biochem       Date:  2006-03       Impact factor: 5.080

7.  Anti-inflammatory and anti-infectious effects of Evodia rutaecarpa (Wuzhuyu) and its major bioactive components.

Authors:  Jyh-Fei Liao; Wen-Fei Chiou; Yuh-Chiang Shen; Guei-Jane Wang; Chieh-Fu Chen
Journal:  Chin Med       Date:  2011-02-14       Impact factor: 5.455

Review 8.  Pharmacological effects of rutaecarpine as a cardiovascular protective agent.

Authors:  Sujie Jia; Changping Hu
Journal:  Molecules       Date:  2010-03-15       Impact factor: 4.411

9.  Low-cytotoxic synthetic bromorutaecarpine exhibits anti-inflammation and activation of transient receptor potential vanilloid type 1 activities.

Authors:  Chi-Ming Lee; Jiun-An Gu; Tin-Gan Rau; Che-Hsiung Yang; Wei-Chi Yang; Shih-Hao Huang; Feng-Yen Lin; Chun-Mao Lin; Sheng-Tung Huang
Journal:  Biomed Res Int       Date:  2013-11-28       Impact factor: 3.411

10.  Involvement of TRPV1 in the expression and release of calcitonin gene-related peptide induced by rutaecarpine.

Authors:  Yongmei Yang; Qingquan Chen; Sujie Jia; Limei He; Aiping Wang; Dai Li; Yuanjian Li; Xiaohui Li
Journal:  Mol Med Rep       Date:  2018-01-25       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.